levodopa has been researched along with neurotensin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bissette, G; Lipton, MA; Loosen, PT; Manberg, PJ; Nemeroff, CB; Prange, AJ; Wilson, IC | 1 |
| De Ceballos, ML; Jenner, P; Marsden, CD; Rose, S; Taylor, MD | 1 |
| Hulting, AL; Meister, B | 1 |
| Ervin, GN; Nemeroff, CB | 1 |
| Barkemeyer, CA; Hawkins, MF; Tulley, RT | 1 |
| Boyce, S; De Ceballos, ML; Jenner, P; Marsden, CD | 1 |
| Chartoff, EH; Dorsa, DM; Palmiter, RD; Szczypka, MS | 1 |
| Landry, E; Lévesque, D; Rouillard, C; St-Hilaire, M | 1 |
| Bobkova, NV; Bondarenko, NA; Gudasheva, TA; Ostrovskaya, RU; Retyunskaya, MV; Samokhin, AN | 1 |
| Bourhis, E; Lévesque, D; Rouillard, C; St-Hilaire, M | 1 |
1 review(s) available for levodopa and neurotensin
| Article | Year |
|---|---|
Pharmaco-behavioral effects of hypothalamic peptides in animals and man: focus on thyrotropin-releasing hormone and neurotensin.
Topics: Animals; Behavior, Animal; Body Temperature; Brain; Dihydroxyphenylalanine; Drug Synergism; Humans; Hypnotics and Sedatives; Hypothalamus; Levodopa; Mental Disorders; Neural Inhibition; Neurotensin; Neurotransmitter Agents; Serotonin; Thyrotropin-Releasing Hormone | 1978 |
9 other study(ies) available for levodopa and neurotensin
| Article | Year |
|---|---|
Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
Topics: Animals; Carbidopa; Cholecystokinin; Chromatography, High Pressure Liquid; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neuropeptides; Neurotensin; Oxidopamine; Prosencephalon; Rats; Rats, Wistar; Substance P; Substantia Nigra | 1992 |
Influence of coexisting hypothalamic messengers on growth hormone secretion from rat anterior pituitary cells in vitro.
Topics: Animals; Cells, Cultured; Dopamine; Galanin; gamma-Aminobutyric Acid; Growth Hormone; Growth Hormone-Releasing Hormone; Hypothalamus; Levodopa; Male; Neurotensin; Peptides; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains | 1987 |
Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin.
Topics: Animals; Ascorbic Acid; Brain; Dopamine; Hydroxydopamines; Injections; Levodopa; Male; Motor Activity; Neurotensin; Norepinephrine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Septal Nuclei; Stereotyped Behavior | 1988 |
Synergistic effects of dopamine agonists and centrally administered neurotensin on feeding.
Topics: Animals; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Eating; Hypothalamus; Injections; Injections, Intraventricular; Levodopa; Male; Neurotensin; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats.
Topics: Animals; Basal Ganglia; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neurotensin; Pergolide; Rats; Rats, Inbred Strains; Trifluoperazine | 1986 |
Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Topics: Age Factors; Animals; Behavior, Animal; Benzazepines; Carbidopa; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Gene Expression; Haloperidol; In Situ Hybridization; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Neurotensin; Pyrazoles; Quinolines; Receptors, Neurotensin; RNA, Messenger; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase | 2004 |
Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
Topics: Animals; Corpus Striatum; Denervation; Disease Models, Animal; DNA-Binding Proteins; Dopamine; Dopamine Antagonists; Dynorphins; Enkephalins; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Levodopa; Male; Neurons; Neurotensin; Nuclear Receptor Subfamily 4, Group A, Member 1; Parkinson Disease; Phenotype; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Dopamine D1; Receptors, Dopamine D3; Receptors, Steroid; RNA, Messenger; Transcription Factors; Tyrosine 3-Monooxygenase | 2005 |
Cholinopositive effect of dilept (neurotensin peptidomimetic) as the basis of its mnemotropic effect.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Benserazide; Drug Combinations; Levodopa; Male; Memory; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Neurotensin; Olfactory Bulb; Peptides; Rats; Rats, Wistar; Receptors, Muscarinic; Schizophrenia; Scopolamine; Space Perception | 2005 |
Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
Topics: Adaptation, Physiological; Animals; Antiparkinson Agents; Benserazide; Corpus Striatum; Denervation; Disease Models, Animal; DNA-Binding Proteins; Dopamine; Dopamine Agents; Drug Resistance; Enkephalins; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neural Pathways; Neurotensin; Nuclear Receptor Subfamily 4, Group A, Member 1; Parkinson Disease; Receptors, Cytoplasmic and Nuclear; Receptors, Dopamine D3; Receptors, Steroid; Transcription Factors | 2006 |